Beta anomer raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-03-15 and is reviewed periodically as new material appears.
NMN is present in small amounts in some foods, including certain vegetables, fruits, and animal products, but food content varies widely and is not well standardized. In laboratory research, NMN is used as a tool compound to study NAD+ metabolism, mitochondrial function, and cellular stress responses. Animal studies have reported changes in NAD+ levels and various physiological measures after NMN administration, but species differences and study designs limit direct extrapolation to humans. Human trials have largely focused on safety, tolerability, and pharmacokinetics, with fewer studies examining clinical endpoints.
Nicotinamide mononucleotide, commonly abbreviated NMN, is a naturally occurring nucleotide. Its structure consists of a nicotinamide ring attached to a ribose sugar that carries a phosphate group. The molecular formula is C11H15N2O8P, and the molar mass is about 334.22 grams per mole. In cells, NMN is an intermediate in the salvage pathway that recycles nicotinamide to maintain NAD+ levels. It is not the same compound as NAD+, although it is a direct precursor in one enzymatic step.
Inside cells, the enzyme nicotinamide phosphoribosyltransferase, or NAMPT, converts nicotinamide and a ribose-phosphate donor into NMN. A second enzyme, NMN adenylyltransferase, then converts NMN into NAD+. NAD+ participates in redox reactions and serves as a substrate for signaling enzymes such as sirtuins, PARPs, and CD38. Because NAD+ levels tend to decline with age in many organisms, NMN has drawn interest as a possible way to influence that decline. Whether oral NMN reliably raises NAD+ in human tissues, and whether any such change modifies disease risk, remain open research questions.
Analytical laboratories identify and quantify NMN using several complementary techniques. High-performance liquid chromatography with ultraviolet detection is widely used for purity and assay work. Liquid chromatography coupled to mass spectrometry provides greater sensitivity and is common for biological matrices. Nuclear magnetic resonance spectroscopy supports structural confirmation and can distinguish related nucleotides. Accurate measurement depends on reference standards, validated methods, and careful sample preparation, especially because NMN can convert to related compounds under some conditions.
Regulatory treatment of NMN varies by jurisdiction and has changed over time. Some countries allow it in dietary supplements, while others treat it as a novel food ingredient requiring safety review. In the United States, the Food and Drug Administration has questioned whether NMN can be lawfully marketed as a dietary supplement because of drug preclusion provisions. Sports organizations have separate rules, and NMN is not currently on the World Anti-Doping Agency prohibited list. These differences create uncertainty for manufacturers, retailers, and researchers seeking consistent legal pathways.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C11H15N2O8P | Identifies the atoms in the nucleotide |
| Molar mass | 334.22 g/mol | Calculated from the molecular formula |
| Appearance | White to off-white powder | Typical for purified solid material |
| Solubility | Water-soluble | Polar nucleotide; less soluble in nonpolar solvents |
| Common synonyms | Nicotinamide mononucleotide; beta-NMN | beta-NMN refers to the common anomeric form |
Chemically, NMN is described by the molecular formula C11H15N2O8P and a molecular mass near 334.22 g/mol. The beta anomer has a CAS Registry Number of 1094-61-7. It is typically supplied as a white to off-white powder for laboratory use. The molecule carries a phosphate group and a positively charged nicotinamide ring, giving it polar and water-soluble character. These properties influence how it is detected, purified, and stored in research and analytical laboratories.
Nicotinamide mononucleotide, abbreviated NMN, is a nucleotide composed of nicotinamide, ribose, and phosphate. Its structure links nicotinamide to D-ribose 5-phosphate through a glycosidic bond, placing it in the pyridine nucleotide family. The compound exists in alpha and beta anomeric forms, and the beta form is the one used in NAD+ biosynthesis. NMN is not a protein or a hormone; it is a small water-soluble molecule that occurs in living cells as a metabolic intermediate.
Stability testing examines how temperature, humidity, light, and pH affect NMN over time. The compound is generally stored cold, often at minus twenty degrees Celsius or lower, in a desiccated container protected from light. Aqueous solutions tend to be less stable than dry powder because hydrolysis and dephosphorylation can occur, potentially forming nicotinamide riboside or other degradation products. Stress studies may expose samples to heat, acid, base, oxidation, and strong light to identify likely degradation pathways. Results from such studies help define shelf life and handling recommendations, though exact stability depends on formulation and packaging.
Quality control for NMN materials typically includes identity, assay, purity, and impurity profiling. Tests may cover residual solvents, heavy metals, microbial limits, and water content, depending on the intended use and local rules. Impurity profiles can include related substances such as nicotinamide, nicotinamide riboside, and NAD+, which may form during synthesis or storage. Because commercial NMN can be offered as different salts or hydrate forms, a certificate of analysis should state the form and the analytical methods used. Independent verification is relevant because supplement markets vary in testing requirements and enforcement.
The Quantum-Mechanical Calculation of the Resonance Energy of Benzene and Naphthalene and the Hydrocarbon Free Radicals" (PDF). The Journal of Chemical Physics. 1 (6): 362. Bibcode:1933JChPh...1..362P. doi:10.1063/1.1749304. Archived (PDF) from the original on 2022-10-09. —— (1935). "The Structure and Entropy of Ice and of Other Crystals with Some Randomness of Atomic Arrangement". Journal of the American Chemical Society. 57 (12): 2680–2684. Bibcode:1935JAChS..57.2680P. doi:10.1021/ja01315a102. —— (1940). "A Theory of the Structure and Process of Formation of Antibodies*". Journal of the American Chemical Society. 62 (10): 2643–2657. Bibcode:1940JAChS..62.2643P. doi:10.1021/ja01867a018. —— (1947). "Atomic Radii and Interatomic Distances in Metals". Journal of the American Chemical Society. 69 (3): 542–553. Bibcode:1947JAChS..69..542P. doi:10.1021/ja01195a024. ——; Itano, H. A.; Singer, S. J.; Wells, I. C. (1949). "Sickle Cell Anemia, a Molecular Disease". Science. 110 (2865): 543–548. Bibcode:1949Sci...110..543P. doi:10.1126/science.110.2865.543. PMID 15395398. S2CID 31674765. ——; Corey, R. B.; Branson, H. R. (1951). "The structure of proteins: Two hydrogen-bonded helical configurations of the polypeptide chain". Proceedings of the National Academy of Sciences. 37 (4): 205–11. Bibcode:1951PNAS...37..205P. doi:10.1073/pnas.37.4.205. PMC 1063337. PMID 14816373. —— (1964). "The Architecture of Molecules". Proceedings of the National Academy of Sciences. 51 (5): 977–984. Bibcode:1964PNAS...51..977P. doi:10.1073/pnas.51.5.977. ISSN 0027-8424. PMC 300194. PMID 16591181.
On January 16, 2013, Nigel Travis, Dunkin' Brands CEO, announced that the Dunkin' Donuts franchises would be available for the first time in California beginning in 2015 although in reality, this was a return to California, as the company had several stores operating in the state up until 2002. In July 2013, Dunkin' Donuts announced that it signed its first Southern California multi-unit store development agreements with four franchise groups for a total commitment of 45 new restaurants. The first standalone restaurants were expected to open in 2015 in Orange and Los Angeles counties. The chain also planned to expand into more stores in Texas by 2015.
Due to its success in livestock operations cryobranding has attracted the attention of humans in pursuit of novel body modifications. It remains a rare practice, with many instances carried out in an amateur setting. Most report pain, edema and sloughing of skin. Branding times vary but most are strongly overbranded, perhaps due a naive assumption that human skin requires the same brand durations as those of cattle and horses. Branding times up to 30 seconds have been recorded, although even 10 seconds have proved sufficient to produce a third degree cryoburn. This instance of a 10-second freeze brand formed the basis of the first medical report on a case of human cryobranding. The case involved a 33-year-old woman who received a large runic cryobrand to her inner forearm. The brand was cooled in a dry ice isopropanol bath for 5 minutes and then applied to her hairless skin for 10 seconds. The woman developed a third degree burn at the center of the imprint and sought medical attention 18 days after being branded. Her wound was treated with the same protocol for thermal burns and closed approximately 8 weeks after branding and 5 weeks after treatment began. At six months the final brand was somewhat hyperpigmented, with a central scar from the open wound. The mild steel branding iron used in this case bore a combination of two vowels from the Elder Futhark alphabet, an ᛁ superimposed on a ᛟ (equivalent to the English vowels i and o). Ranchers strongly advise that a gap be left in a brand face where the pattern has crossing lines.
==== Distribution ==== Labetalol is often classified as a beta blocker with low lipophilicity and hence lower potential for crossing the blood–brain barrier and blood–placenta barrier. This in turn may result in fewer effects in the central nervous system as well as a lower risk of neuropsychiatric side effects. Paradoxically however, labetalol actually shows high lipophilicity. In any case, labetalol, in animals including rats, rabbits, and dogs, was found to cross into the brain in negligible amounts, probably for reasons other than low lipophilicity. On the other hand, the drug has been shown to cross the blood–placenta barrier in humans.
Sources: en.wikipedia.org
== Liquid-phase reactions == Chemiluminescence was first observed with lophine (triphenylimidazole). When in basic solution, this compound converts to imidazolate, which reacts with oxygen to eventually give a dioxetane. Fragmentation of dioxetane gives the excited state of an anionic diamide.
=== Human food supply outside of U.S. === On 7 June 2007, the European Food Safety Authority (EFSA) issued a provisional statement, noting that they were investigation potential synergistic effects between melamine and cyanuric acid. However, by 21 June, the Health & Consumer Protection Directorate-General of the European Commission found that there was "no need to take restrictive measures" on livestock who had eaten contaminated feed, nor on food products derived from such animals. In 2008, the reports of contaminated powdered milk in China led to renewed examination of potential health risks. The EFSA issued a press release on 25 September 2008, noting that children who consumed above-average levels of milk products could potentially be at risk. A report from the Chinese Ministry of Health found that 294,000 infants in China had been affected by melamine-contaminated infant formula by the end of November 2008. More than 50,000 infants were hospitalized, and six deaths were confirmed, as a result of this contamination.
An ultraviolet detector (also known as UV detector or UV-Vis detector) is a type of non-destructive chromatography detector which measures the amount of ultraviolet or visible light absorbed by components of the mixture being eluted off the chromatography column. They are often used as detectors for high-performance liquid chromatography. The vast majority of liquid chromatographic systems are equipped with ultraviolet (UV) absorption detectors. The most common UV-Vis detectors used are variable wavelength detectors (VWD), photo diode array detectors (PDA), and diode array detectors (DAD). Variable wavelength detectors decide in advance which wavelength is needed for the detection. Its absorbance as function of time is collected in a graphic format called a chromatogram. As can be seen in Figure 1, these detectors have a light source, a dispersion element that is a diffraction grating or prism, a flow cell, to where the sample arrives directly from the chromatographic column, an optical bench of lenses and mirrors, and a diode that receives the light coming from the optical system and translates it into a signal proportional to light intensity. When the user selects a wavelength for the detector, the optical system rotates the grating or prism in the space, so that the desired wavelength passes through optical system, then the flow cell and reaches the diode. The UV/Vis detector then produces a chromatogram as a two-dimensional (2D) output. This output plots time on the x-axis and response in absorbance units (AU) on the y-axis.
According to Druze tradition, Jesus sought sanctuary on this summit and held a clandestine meeting with his disciples there. Druze believe that Hamza ibn Ali was a reincarnation of Jesus, and that Hamza ibn Ali is the true Messiah, who directed the deeds of the Messiah Jesus "the son of Joseph and Mary", but when Jesus "the son of Joseph and Mary" strayed from the path of the true Messiah, Hamza filled the hearts of the Jews with hatred for him – and for that reason, they crucified him, according to the Druze manuscripts. Despite this, Hamza ibn Ali took him down from the cross and allowed him to return to his family, to prepare men for the preaching of his religion. In an epistle ascribed to one of the founders of Druzism, Baha al-Din al-Muqtana, probably written sometime between AD 1027 and AD 1042, accused the Jews of crucifying Jesus. The Druze believe that each spokesmen or prophets (natiq) has a "foundation" or "guardian" who is responsible for the esoteric, interpretative law, while the spokesmen or prophets (natiq) himself presents the apparent, obligatory law. According to Druze belief, Jesus, son of Joseph and Mary, the first limit and fifth spokesman or prophet natiq, appeared and replaced Moses' law with his own, proclaiming his message and appointing Simon Peter (Sham'un al-Safa) as his foundation. He had twelve apostles who called people to worship and unify the God and to obey Jesus, considered the son of the God the Father. However, his followers did not fully understand his words and symbols.
=== Veterinary products === The Center for Veterinary Medicine (CVM) is a center of the FDA that regulates food additives and drugs that are given to animals. CVM regulates animal drugs, animal food including pet animal, and animal medical devices. The FDA's requirements to prevent the spread of bovine spongiform encephalopathy are also administered by CVM through inspections of feed manufacturers. CVM does not regulate vaccines for animals; these are handled by the United States Department of Agriculture.
Sources: en.wikipedia.org
Besides directing the order of assembly, the standard BASIC linkers can also be modified to carry out other functions. To allow for idempotent assembly, linkers were also designed with additional methylated iP and iS sequences inserted to protect them from being recognised by BsaI. This methylation is lost following transformation and in vivo plasmid replication, and the plasmids can be extracted, purified, and used for further reactions. Because the linker sequence are relatively long (45bp for a standard linker), there is an opportunity to incorporate functional DNA sequences to reduce the number of DNA parts needed during assembly. The BASIC assembly standard provides several linkers embedded with RBS of different strengths. Similarly to facilitate the construction of fusion proteins containing multiple protein domains, several fusion linkers were also designed to allow for full read-through of the DNA construct. These fusion linkers code for a 15 amino acid glycine and serine polypeptide, which is an ideal linker peptide for fusion proteins with multiple domains.
== Research directions == A 2022 review concluded that according to low-certainty evidence, fluvoxamine may slightly decrease all-cause mortality by day 28 and potentially reduce the risk of hospitalization or death in outpatients with mild COVID-19. While early studies have suggested potential benefits for fluvoxamine as an anti-inflammatory agent and a possible impact on reducing cytokine storms, further studies did not confirm this expected benefit on COVID-19 patients. A cytokine storm refers to an excessive immune response characterized by a release of large amounts of pro-inflammatory cytokines. In May 2022, based on a review of available scientific evidence, the U.S. Food and Drug Administration (FDA) did not issue an emergency use authorization covering the use of fluvoxamine to treat COVID-19, saying that, at the time, the data was not sufficient to conclude that fluvoxamine may be effective in treating non-hospitalized people with COVID-19 to prevent serious illness or hospitalization. The agency stated that the available study results were not conclusive on whether fluvoxamine is effective for this use. Reviews published in 2024 indicate that clinical trials have shown fluvoxamine to be more effective than a placebo in reducing clinical deterioration and hospitalization in COVID-19 patients, particularly those taking 200 mg or more daily.
== Medical use == Paclitaxel is approved in the UK for ovarian, breast, lung, bladder, prostate, melanoma, esophageal, and other types of solid tumor cancers as well as Kaposi's sarcoma. It is recommended in National Institute for Health and Care Excellence (NICE) guidance of June 2001 for non-small-cell lung cancer in patients unsuitable for curative treatment, and in first-line and second-line treatment of ovarian cancer. In September 2001, NICE recommended paclitaxel for the treatment of advanced breast cancer after the failure of anthracyclic chemotherapy, but that its first-line use should be limited to clinical trials. In September 2006, NICE recommended paclitaxel should not be used in the adjuvant treatment of early node-positive breast cancer. It is approved in the United States for the treatment of breast, pancreatic, ovarian, Kaposi's sarcoma and non-small-cell lung cancers.
Taxidermy is the art of preserving an animal's body by mounting (over an armature) or stuffing, for the purpose of display or study. Animals are often, but not always, portrayed in a lifelike state. The word taxidermy describes the process of preserving the animal, but the word is also used to describe the end product, which are called taxidermy mounts or referred to simply as "taxidermy". The word taxidermy is derived from the Ancient Greek words τάξις taxis (order, arrangement) and δέρμα derma (skin). Thus taxidermy translates to "arrangement of skin". Taxidermy is practiced primarily on vertebrates (mammals, birds, fish, reptiles, and less commonly on amphibians) but can also be done to larger insects and arachnids under some circumstances. Taxidermy takes on a number of forms and purposes including hunting trophies and natural history museum displays. Unlike meat harvesting, taxidermy does not require killing an animal that could have otherwise remained alive. Museums use taxidermy as a method to record species, including those that are extinct and threatened, in the form of study skins and life-size mounts. Taxidermy is sometimes also used as a means to memorialize pets. A person who practices taxidermy is called a taxidermist. They may practice professionally, catering to museums and sportspeople (hunters and fishers), or as amateurs (hobbyists). A taxidermist is aided by familiarity with anatomy, sculpture, painting, and tanning.
Sources: en.wikipedia.org
NMN stands for nicotinamide mononucleotide. It is a nucleotide intermediate in the cellular pathway that produces NAD+, a coenzyme involved in energy metabolism and signaling. NMN is not the same compound as NAD+.
NMN is a direct precursor to NAD+ in the salvage pathway. The enzyme NMNAT converts NMN into NAD+ by adding an adenine nucleotide group. This relationship is why NMN is studied in the context of NAD+ decline.
Yes, NMN is produced naturally in cells as part of NAD+ recycling. It also appears in small and variable amounts in some foods. Its natural presence does not by itself establish that supplemental NMN has clinical benefits.
Solid NMN is often kept cool, dry, and protected from light. Long-term storage may use temperatures at or below minus twenty degrees Celsius. Moisture and repeated temperature changes should be avoided.